Grp | n | Infection profile (Ref assay)a | Dual-label assay (HIV-1+/HBV+)b |
|---|
In-house sera panel |
1 | 25 | HIV-1-/HBV+ | 0/23c |
2 | 12 | HIV-1+/HBV- | 12/0 |
BBI co-infection panel |
3 | 13 | HIV-1+/HBV+ | 13/10d |
4 | 6 | HIV-1-/HBV+ | 0/6 |
5 | 3 | HIV-1+/HBV- | 3/0 |
6 | 1 | HIV-1-/HBV- | 0/0 |
- a The Reference assays for the in-house sera panel were Vidas HIV Duo Quick and HBsAg Ultra assays, for anti-HIV-1 antibody and HBsAg detection, respectively; the Reference assays for the BBI co-infection panel are mentioned in the Supplementary Information (see Additional file 1). The "+" and "-" superscripts indicate positive and negative tests, respectively.
- b This column indicates the results obtained using the dual-label assay described in the text. The numbers shown indicate the serum samples that scored positive for both analytes in the dual-label assay.
- cmissed two HBsAg+ serum samples
- dmissed three HBsAg+ serum samples
